You might be technically right. However when they announced AXF's commitment for second stage $5m the normal logic would say they may have exhausted the first $m.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025